Fondazione Policlinico Gemelli Università Cattolica

Roma 168

0 studies enrolling now · 3 studies all time

What they study most

Crohn Disease, Ulcerative Colitis

Studies at this site

• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease — Completed